These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7488241)

  • 1. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.
    Toffoli G; Simone F; Corona G; Raschack M; Cappelletto B; Gigante M; Boiocchi M
    Biochem Pharmacol; 1995 Oct; 50(8):1245-55. PubMed ID: 7488241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
    Toffoli G; Corona G; Gigante M; Boiocchi M
    Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
    Toffoli G; Simone F; Gigante M; Boiocchi M
    Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil.
    Pesić M; Podolski A; Rakić L; Ruzdijić S
    Invest New Drugs; 2010 Aug; 28(4):482-92. PubMed ID: 19533022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
    Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M
    Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity.
    Lee BH; Lee CO; Kwon MJ; Yi KY; Yoo SE; Choi SU
    Anticancer Drugs; 2003 Feb; 14(2):175-81. PubMed ID: 12569305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
    Toffoli G; Corona G; Sorio R; Bertola A; Boiocchi M
    Int J Cancer; 1997 May; 71(5):900-6. PubMed ID: 9180163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
    Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K
    Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.
    Liu Y; Cho CW; Yan X; Henthorn TK; Lillehei KO; Cobb WN; Ng KY
    Pharm Res; 2001 Sep; 18(9):1255-61. PubMed ID: 11683237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
    Nygren P; Larsson R; Gruber A; Peterson C; Bergh J
    Br J Cancer; 1991 Dec; 64(6):1011-8. PubMed ID: 1684906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line.
    Huang M; Liu G
    Cancer Lett; 1999 Jan; 135(1):97-105. PubMed ID: 10077227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells.
    Teodori E; Braconi L; Bua S; Lapucci A; Bartolucci G; Manetti D; Romanelli MN; Dei S; Supuran CT; Coronnello M
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
    Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
    Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation.
    Hu YP; Chapey C; Robert J
    Cancer Lett; 1996 Dec; 109(1-2):203-9. PubMed ID: 9020922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.